P293 The effect of zoledronic acid on bone mineral density and bone turnover in patients with early breast cancer on the AZURE trial

10.1016/s0960-9776(11)70235-1 ◽

2011 ◽

Vol 20 ◽

pp. S71

Author(s):

C. Shankland ◽

R. Coleman

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Turnover ◽

Early Breast Cancer ◽

Bone Mineral ◽

Mineral Density

Download Full-text

142P Bone mineral density (BMD) after three years of adjuvant zoledronic acid (ZA) in postmenopausal oestrogen receptor positive (ER+) early breast cancer (EBC): An observational single centre study

Annals of Oncology ◽

10.1016/j.annonc.2021.03.156 ◽

2021 ◽

Vol 32 ◽

pp. S82

Author(s):

C. Harper-Wynne ◽

R. Burcombe

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Early Breast Cancer ◽

Bone Mineral ◽

Oestrogen Receptor ◽

Mineral Density ◽

Single Centre ◽

Centre Study ◽

Single Centre Study

Download Full-text

369 The effect of exemestane and anastrozole on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: final results of 3 years after randomization of N-SAS (national surgical adjuvant study) BC04, the TEAM Japan sub-study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70395-5 ◽

2010 ◽

Vol 8 (3) ◽

pp. 165 ◽

Author(s):

Y. Hozumi ◽

T. Aihara ◽

N. Suemasu ◽

H. Takei ◽

M. Takehara ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Bone Turnover ◽

Cancer Patients ◽

Early Breast Cancer ◽

Bone Mineral ◽

Bone Turnover Markers ◽

Breast Cancer Patients ◽

Mineral Density ◽

Turnover Markers

Download Full-text

Effects of Exemestane, Anastrozole and Tamoxifen on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Early Breast Cancer Patients: Results of N-SAS BC 04, the TEAM Japan Substudy

Oncology ◽

10.1159/000323489 ◽

2010 ◽

Vol 79 (5-6) ◽

pp. 376-381 ◽

Author(s):

T. Aihara ◽

K. Suemasu ◽

H. Takei ◽

Y. Hozumi ◽

M. Takehara ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Bone Turnover ◽

Cancer Patients ◽

Early Breast Cancer ◽

Bone Mineral ◽

Bone Turnover Markers ◽

Breast Cancer Patients ◽

Mineral Density ◽

Turnover Markers

Download Full-text

The Assessment of Bone Mineral Density (BMD) and Fracture Risk after 3 Years of Adjuvant Zoledronic Acid in Postmenopausal (ER+) Early Breast Cancer

Clinical Oncology ◽

10.1016/j.clon.2020.02.015 ◽

2020 ◽

Vol 32 (8) ◽

pp. e169

Author(s):

G. Eslamian ◽

C. Harper-Wynne

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Fracture Risk ◽

Early Breast Cancer ◽

Bone Mineral ◽

Mineral Density

Download Full-text

Faculty Opinions recommendation of Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13377017.14747132 ◽

2011 ◽

Author(s):

James Triffitt ◽

Xuchen Duan

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Turnover ◽

Bone Mineral ◽

Secondary Osteoporosis ◽

Mineral Density

Download Full-text

14 Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70046-x ◽

2010 ◽

Vol 8 (3) ◽

pp. 62

Author(s):

P. Hadji ◽

A. Kauka ◽

M. Kalder ◽

T. Bauer ◽

U. Albert ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Adjuvant Chemotherapy ◽

Bone Mineral ◽

Hormone Receptor ◽

Premenopausal Women ◽

Endocrine Treatment ◽

Mineral Density ◽

Hormone Receptor Positive

Download Full-text

Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study

Orthopaedic Surgery ◽

10.1111/os.12307 ◽

2017 ◽

Vol 9 (1) ◽

pp. 103-109 ◽

Author(s):

Bo-cheng Liang ◽

Zhen-yu Shi ◽

Bo Wang ◽

Peng Wu ◽

Ling-cheng Kong ◽

...

Keyword(s):

Bone Mineral Density ◽

Clinical Study ◽

Zoledronic Acid ◽

Bone Turnover ◽

Bone Mineral ◽

Bone Turnover Markers ◽

Newly Diagnosed ◽

Mineral Density ◽

Turnover Markers

Download Full-text

Five-year follow-up results of aerobic and circuit training on bone mineral density in early breast cancer patients

European Journal of Cancer ◽

10.1016/s0959-8049(20)30747-4 ◽

2020 ◽

Vol 138 ◽

pp. S81

Author(s):

C. Blomqvist ◽

L. Vehmanen ◽

H. Sievänen ◽

P. Kellokumpu-Lehtinen ◽

R. Nikander ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Cancer Patients ◽

Early Breast Cancer ◽

Bone Mineral ◽

Breast Cancer Patients ◽

Mineral Density ◽

Circuit Training

Download Full-text

The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2009.09.026 ◽

2009 ◽

Vol 45 (18) ◽

pp. 3205-3212 ◽

Author(s):

Peyman Hadji ◽

May Ziller ◽

Carolin Maskow ◽

Ute Albert ◽

Matthias Kalder

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Bone Turnover ◽

Bone Mineral ◽

Mineral Density ◽

Menopausal Women ◽

Quantitative Ultrasonometry

Download Full-text

Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study

Osteoporosis International ◽

10.1007/s00198-013-2615-z ◽

2014 ◽

Vol 25 (4) ◽

pp. 1369-1378 ◽

Author(s):

P. Hadji ◽

A. Kauka ◽

M. Ziller ◽

K. Birkholz ◽

M. Baier ◽

...

Keyword(s):

Breast Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Mineral ◽

Premenopausal Women ◽

Mineral Density ◽

Adjuvant Therapies

Download Full-text